US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Korro Bio, Inc.

18.09

+0.65003.73%

Post-market: 18.00-0.0900-0.50%18:41 EDT

Volume:50.68K

Turnover:888.76K

Market Cap:169.85M

PE:-1.93

High:18.09

Open:17.32

Low:16.44

Close:17.44

Loading ...

Overview Company News Filings

Korro Bio Inc - CEO Ram Aiyar Appointed Interim Principal Financial Officer

THOMSON REUTERS

Korro Bio announces initiation of dosing in its REWRITE study on KRRO-110

Korro Bio Announces Dosing of First Participants in Rewrite Phase 1/2a Study of Krro-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

THOMSON REUTERS

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

Oppenheimer Initiates Korro Bio at Outperform With $155 Price Target

MT Newswires Live

Why Korro Bio (KRRO) Should Be on Your Investment Radar

Korro Bio Files Mixed Shelf Registration

MT Newswires Live

Korro Bio Inc Files for Mixed Shelf of up to $400 Mln – SEC Filing

THOMSON REUTERS

Korro Bio: “at Market Offering” Prospectus Offering of up to $100 Mln Common Stock That May Be Issued From Time to Time

THOMSON REUTERS

We Think Korro Bio (NASDAQ:KRRO) Needs To Drive Business Growth Carefully

Simply Wall St.

Korro Bio Price Target Maintained With a $115.00/Share by HC Wainwright & Co.

BRIEF-Korro Receives Australian HREC Approval and CTN Clearance

Korro Bio Inc - First Participant Dosing Expected in Q1 2025

THOMSON REUTERS

Korro Receives Australian Hrec Approval and Ctn Clearance to Initiate Phase 1/2a Clinical Study (Rewrite) of Krro-110 for Alpha-1 Antitrypsin Deficiency

THOMSON REUTERS

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

JonesTrading Initiates Korro Bio at Buy With $130 Price Target

MT Newswires Live

Korro Bio initiated with a Buy at JonesResearch

U.S. RESEARCH ROUNDUP- Airbnb, Post Holdings, Syndax Pharmaceuticals

Korro Bio Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $130

THOMSON REUTERS

Korro Bio Price Target Maintained With a $115.00/Share by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KRRO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":18.09,"timestamp":1745611200000,"preClose":17.44,"halted":0,"volume":50683,"hourTrading":{"tag":"盘后","latestPrice":18,"preClose":18.09,"latestTime":"18:41 EDT","volume":554,"amount":10011.45,"timestamp":1745620870599},"delay":0,"floatShares":4913476,"shares":9388902,"eps":-9.369477,"marketStatus":"Market Closed","change":0.65,"latestTime":"04-25 16:00:00 EDT","open":17.32,"high":18.09,"low":16.4368,"amount":888761.021489,"amplitude":0.094794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.369477,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":17.44,"preHourTrading":{"tag":"盘前","latestPrice":17.01,"preClose":17.44,"latestTime":"04:04 EDT","volume":1,"amount":17.01,"timestamp":1745568268688},"postHourTrading":{"tag":"盘后","latestPrice":18,"preClose":18.09,"latestTime":"18:41 EDT","volume":554,"amount":10011.45,"timestamp":1745620870599},"volumeRatio":0.3508830229117011},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","floatShares":4913476,"roa":"-25.65%","roe":"-50.61%","lyrEps":-9.369477,"volumeRatio":0.3508830229117011,"shares":9388902,"dividePrice":0,"high":18.09,"amplitude":0.094794,"preClose":17.44,"low":16.4368,"week52Low":11.13,"pbRate":"1.06","psRate":"74.79","week52High":98,"institutionHeld":0,"latestPrice":18.09,"eps":-9.369477,"divideRate":0,"volume":50683,"delay":0,"ttmEps":-9.369477,"open":17.32,"prevYearClose":38.07,"prevWeekClose":13.9,"prevMonthClose":17.41,"prevQuarterClose":17.41,"fiveDayClose":13.9,"twentyDayClose":18.38,"sixtyDayClose":33.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRRO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510478357","title":"Korro Bio Inc - CEO Ram Aiyar Appointed Interim Principal Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2510478357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510478357?lang=en_us&edition=fundamental","pubTime":"2025-02-12 05:21","pubTimestamp":1739308872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P212I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2503304182","title":"Korro Bio announces initiation of dosing in its REWRITE study on KRRO-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2503304182","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503304182?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:36","pubTimestamp":1736775375,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) announced the initiation of dosing in its REWRITE study investigating KRRO-110 as a potential treatment for individuals with Alpha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-announces-initiation-of-dosing-in-its-rewrite-study-on-krro-110?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-announces-initiation-of-dosing-in-its-rewrite-study-on-krro-110?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2503586309","title":"Korro Bio Announces Dosing of First Participants in Rewrite Phase 1/2a Study of Krro-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2503586309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503586309?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA5RVM9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2503309402","title":"Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309402","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309402?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"KRRO-110 is the first product candidate from Korro’s proprietary RNA editing OPERATM platform. Interim readout from REWRITE expected in the second half of 2025. Korro to advance additional pipeline programs towards clinical development. “We have evolved from a research organization to a clinical-stage drug development organization with our first participant in the REWRITE study recently dosed with KRRO-110. We have taken time to build our pipeline to demonstrate the versatility of RNA editing, building on data from other oligonucleotide programs,” said Ram Aiyar, PhD, President and CEO. “Over the next three years, we expect to take three product candidates into the clinic, in two tissue types with a single modular platform. This will be the crux of our 3-2-1 strategy through 2027. I am excited about the prospect that RNA editing holds beyond the treatment of rare genetic disease and applying our platform to highly prevalent diseases.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/korro-bio-announces-dosing-first-130000332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RNA","BK4505","KRRO","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2502389385","title":"Oppenheimer Initiates Korro Bio at Outperform With $155 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2502389385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502389385?lang=en_us&edition=fundamental","pubTime":"2025-01-10 23:27","pubTimestamp":1736522878,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of buy and mean price target of $136.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO","OPY"],"gpt_icon":0},{"id":"2490017068","title":"Why Korro Bio (KRRO) Should Be on Your Investment Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2490017068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490017068?lang=en_us&edition=fundamental","pubTime":"2024-12-10 23:50","pubTimestamp":1733845812,"startTime":"0","endTime":"0","summary":"Biopharma Korro Bio ($KRRO) has been making significant strides in genetic medicine, including developing RNA editing to address rare and widesprea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-korro-bio-krro-should-be-on-your-investment-radar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-korro-bio-krro-should-be-on-your-investment-radar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4505","BK4585","RNA","KRRO"],"gpt_icon":0},{"id":"2488298274","title":"Korro Bio Files Mixed Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2488298274","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488298274?lang=en_us&edition=fundamental","pubTime":"2024-12-03 07:05","pubTimestamp":1733180746,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) filed a registration statement Monday with the US Securities and Exchange Commission covering the potential sale of up to $400 million of its securities from time to time.The filing c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2488986612","title":"Korro Bio Inc Files for Mixed Shelf of up to $400 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2488986612","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488986612?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:22","pubTimestamp":1733174558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N318K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2488866439","title":"Korro Bio:  “at Market Offering” Prospectus Offering of up to $100 Mln Common Stock That May Be Issued  From Time to Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2488866439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488866439?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:22","pubTimestamp":1733174558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N318K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2487327994","title":"We Think Korro Bio (NASDAQ:KRRO) Needs To Drive Business Growth Carefully","url":"https://stock-news.laohu8.com/highlight/detail?id=2487327994","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487327994?lang=en_us&edition=fundamental","pubTime":"2024-11-29 03:01","pubTimestamp":1732820495,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krro/korro-bio/news/we-think-korro-bio-nasdaqkrro-needs-to-drive-business-growth-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2095319765.USD","LU2210150020.SGD",".IXIC","MNQmain","BK4139","QID","NDAQ","BK4585","QLD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","SQQQ","KRRO","PSQ","NQmain","IE00BGHQF748.EUR","BK4588"],"gpt_icon":1},{"id":"2485628254","title":"Korro Bio Price Target Maintained With a $115.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2485628254","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485628254?lang=en_us&edition=fundamental","pubTime":"2024-11-22 20:20","pubTimestamp":1732278000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 22, 2024 07:20 ET (12:20 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2485549887","title":"BRIEF-Korro Receives Australian HREC Approval and CTN Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2485549887","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485549887?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:35","pubTimestamp":1732192534,"startTime":"0","endTime":"0","summary":"BRIEF-Korro Receives Australian HREC Approval and CTN ClearanceNov 21 (Reuters) - Korro Bio Inc KRRO.O:KORRO RECEIVES AUSTRALIAN HREC APPROVAL AND CTN CLEARANCE TO INITIATE PHASE 1/2A CLINICAL STUDY (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA7XZGB7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2485946094","title":"Korro Bio Inc - First Participant Dosing Expected in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2485946094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485946094?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:30","pubTimestamp":1732192201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA7XZGB7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2485904460","title":"Korro Receives Australian Hrec Approval and Ctn Clearance to Initiate Phase 1/2a Clinical Study (Rewrite) of Krro-110 for Alpha-1 Antitrypsin Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2485904460","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485904460?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:30","pubTimestamp":1732192201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA7XZGB7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2485498833","title":"Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2485498833","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485498833?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:30","pubTimestamp":1732192200,"startTime":"0","endTime":"0","summary":"-REWRITE study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of KRRO-110 -First participant dosing anticipated in the first quar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/21/2985116/0/en/Korro-Receives-Australian-HREC-Approval-and-CTN-Clearance-to-Initiate-Phase-1-2a-Clinical-Study-REWRITE-of-KRRO-110-for-Alpha-1-Antitrypsin-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4213","BK4505","BK4585","KRRO","BK4588","TGA","RNA"],"gpt_icon":0},{"id":"2484736856","title":"JonesTrading Initiates Korro Bio at Buy With $130 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2484736856","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484736856?lang=en_us&edition=fundamental","pubTime":"2024-11-18 22:08","pubTimestamp":1731938927,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average outperform rating and a price target range of $105 to $180, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic research from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO"],"gpt_icon":0},{"id":"2484644063","title":"Korro Bio initiated with a Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2484644063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484644063?lang=en_us&edition=fundamental","pubTime":"2024-11-18 18:16","pubTimestamp":1731924982,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Catherine Novack initiated coverage of Korro Bio (KRRO) with a Buy rating and $130 price target Korro is one of a growing num...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-initiated-with-a-buy-at-jonesresearch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-initiated-with-a-buy-at-jonesresearch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2484348619","title":"U.S. RESEARCH ROUNDUP- Airbnb, Post Holdings, Syndax Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2484348619","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484348619?lang=en_us&edition=fundamental","pubTime":"2024-11-18 15:15","pubTimestamp":1731914134,"startTime":"0","endTime":"0","summary":"Nov 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, Post Holdings and Syndax Pharmaceuticals, on Monday.  HIG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1509826696.USD","LU0731783048.USD","POST","LU1235295455.SGD","BK4127","LU0175139822.USD","OVV","BK4023","LU1599440770.SGD","TARS","IE0004445239.USD","TMDX","CAPR","LU0289960550.SGD","LU1720051017.SGD","SG9999003800.SGD","IE00B4JS1V06.HKD","KRRO","BK4107","LU2108987350.USD","BK4588","LU0098860793.USD","LU0106261372.USD","LU1668664300.SGD","LU1989772840.SGD","YELP","ADSK","SNDX","BABA","BK4166","BK4533","INO","PT","LU1989772923.USD","IE00B775H168.HKD","PLD","IE00BJJMRY28.SGD","SGXZ23171101.USD","EFXT","PGR","ABNB","LU0354030511.USD","BK4534","IE0005OL40V9.USD","LU0772969993.USD","MBI","LU2065731478.USD","LU0225283273.USD","PCOR","SG9999011175.SGD"],"gpt_icon":1},{"id":"2484694881","title":"Korro Bio Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $130","url":"https://stock-news.laohu8.com/highlight/detail?id=2484694881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484694881?lang=en_us&edition=fundamental","pubTime":"2024-11-18 12:55","pubTimestamp":1731905751,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nFWN3MP00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2483315408","title":"Korro Bio Price Target Maintained With a $115.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483315408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483315408?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:56","pubTimestamp":1731516960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 11:56 ET (16:56 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-18","symbol":"KRRO","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-2.26},{"market":"US","date":"2024-11-12","symbol":"KRRO","fiscalQuarterEnding":"2024/09","expectedEps":-2.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-2.26},{"market":"US","date":"2024-08-13","symbol":"KRRO","fiscalQuarterEnding":"2024/06","expectedEps":-2.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.43},{"market":"US","date":"2024-05-14","symbol":"KRRO","fiscalQuarterEnding":"2024/03","expectedEps":-2.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-2.44},{"date":"2024-03-26","symbol":"KRRO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711483200000,"name":null,"time":"Post Market","dateTimestamp":1711425600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1744862400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRRO","date":"2025-04-25","current":-1.959087,"percent":0.950581,"low":-8.894386,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"high":-1.441232,"avg":-4.939783,"sd":1.604853,"marketCap":163742450},"quantilePoints":[{"date":"2023-11-10","current":-4.581336,"twenty":-4.600294,"median":-4.593185,"eighty":-4.586076,"marketCap":328848276},{"date":"2023-11-17","current":-4.545683,"twenty":-4.815324,"median":-4.662668,"eighty":-4.586076,"marketCap":326289146},{"date":"2023-11-24","current":-4.263806,"twenty":-4.730727,"median":-4.581336,"eighty":-4.305029,"marketCap":306056020},{"date":"2023-12-01","current":-4.669353,"twenty":-4.669353,"median":-4.511145,"eighty":-4.263806,"marketCap":335166130},{"date":"2023-12-08","current":-5.29327,"twenty":-5.459276,"median":-4.605034,"eighty":-4.305029,"marketCap":379950915},{"date":"2023-12-15","current":-5.927214,"twenty":-5.596315,"median":-4.70004,"eighty":-4.344024,"marketCap":425455455},{"date":"2023-12-22","current":-5.775692,"twenty":-5.775692,"median":-5.29327,"eighty":-4.447639,"marketCap":414579150},{"date":"2023-12-29","current":-5.477103,"twenty":-5.763659,"median":-5.468189,"eighty":-4.46502,"marketCap":393146432},{"date":"2024-01-05","current":-5.57069,"twenty":-5.744941,"median":-5.477103,"eighty":-4.490422,"marketCap":399864150},{"date":"2024-01-12","current":-4.878811,"twenty":-5.700822,"median":-5.48323,"eighty":-4.552814,"marketCap":350201022},{"date":"2024-01-19","current":-4.570194,"twenty":-5.695474,"median":-5.467075,"eighty":-4.570194,"marketCap":328048548},{"date":"2024-01-26","current":-5.793518,"twenty":-5.702159,"median":-5.459276,"eighty":-4.579107,"marketCap":415858716},{"date":"2024-02-02","current":-5.903818,"twenty":-5.702159,"median":-5.475988,"eighty":-4.581336,"marketCap":423776026},{"date":"2024-02-09","current":-6.542219,"twenty":-5.793518,"median":-5.496043,"eighty":-4.605034,"marketCap":469600457},{"date":"2024-02-16","current":-6.005204,"twenty":-5.995177,"median":-5.561777,"eighty":-4.662668,"marketCap":431053553},{"date":"2024-02-23","current":-5.637539,"twenty":-6.009661,"median":-5.57459,"eighty":-4.668016,"marketCap":404662519},{"date":"2024-03-01","current":-5.381287,"twenty":-5.997182,"median":-5.57069,"eighty":-4.718452,"marketCap":386268768},{"date":"2024-03-08","current":-5.46819,"twenty":-5.954177,"median":-5.56679,"eighty":-4.734215,"marketCap":392506649},{"date":"2024-03-15","current":-6.597926,"twenty":-6.029715,"median":-5.57069,"eighty":-4.778761,"marketCap":473599099},{"date":"2024-03-22","current":-7.241897,"twenty":-6.148928,"median":-5.582946,"eighty":-4.827114,"marketCap":519823395},{"date":"2024-03-28","current":-8.749112,"twenty":-6.225581,"median":-5.594644,"eighty":-4.85118,"marketCap":710182879},{"date":"2024-04-05","current":-7.056213,"twenty":-6.445289,"median":-5.625283,"eighty":-4.87168,"marketCap":572766944},{"date":"2024-04-12","current":-7.760846,"twenty":-6.653602,"median":-5.643524,"eighty":-4.982426,"marketCap":629963419},{"date":"2024-04-19","current":-6.599635,"twenty":-6.850878,"median":-5.695474,"eighty":-5.142416,"marketCap":535705553},{"date":"2024-04-26","current":-6.686174,"twenty":-6.869775,"median":-5.765664,"eighty":-5.203025,"marketCap":542730135},{"date":"2024-05-03","current":-6.650761,"twenty":-6.964451,"median":-5.793518,"eighty":-5.219737,"marketCap":539855604},{"date":"2024-05-10","current":-6.269217,"twenty":-6.920952,"median":-5.915516,"eighty":-5.240905,"marketCap":508884843},{"date":"2024-05-17","current":-5.859151,"twenty":-6.869775,"median":-5.859151,"eighty":-5.274998,"marketCap":475317730},{"date":"2024-05-24","current":-5.495668,"twenty":-6.850878,"median":-5.84806,"eighty":-5.34608,"marketCap":445830598},{"date":"2024-05-31","current":-5.743893,"twenty":-6.8128,"median":-5.816278,"eighty":-5.412483,"marketCap":465967596},{"date":"2024-06-07","current":-5.114065,"twenty":-6.734223,"median":-5.793518,"eighty":-5.389162,"marketCap":414873438},{"date":"2024-06-14","current":-4.858019,"twenty":-6.694902,"median":-5.775692,"eighty":-5.295379,"marketCap":394101947},{"date":"2024-06-21","current":-4.102454,"twenty":-6.686174,"median":-5.755637,"eighty":-5.203025,"marketCap":332807503},{"date":"2024-06-28","current":-3.825833,"twenty":-6.685159,"median":-5.743893,"eighty":-5.149649,"marketCap":310366874},{"date":"2024-07-05","current":-4.380219,"twenty":-6.677519,"median":-5.73799,"eighty":-4.872237,"marketCap":355340861},{"date":"2024-07-12","current":-5.240945,"twenty":-6.652589,"median":-5.708166,"eighty":-4.858612,"marketCap":425166453},{"date":"2024-07-15","current":-5.618156,"twenty":-6.652132,"median":-5.702159,"eighty":-4.859205,"marketCap":455767311},{"date":"2024-08-02","current":-4.971182,"twenty":-6.651675,"median":-5.698816,"eighty":-4.859798,"marketCap":403282204},{"date":"2024-08-09","current":-4.113885,"twenty":-6.640451,"median":-5.660935,"eighty":-4.773204,"marketCap":333734802},{"date":"2024-08-16","current":-4.916432,"twenty":-6.613212,"median":-5.643524,"eighty":-4.733343,"marketCap":419376556},{"date":"2024-08-23","current":-4.817231,"twenty":-6.59861,"median":-5.625283,"eighty":-4.733343,"marketCap":410914634},{"date":"2024-08-30","current":-5.446229,"twenty":-6.597297,"median":-5.604672,"eighty":-4.737935,"marketCap":464568797},{"date":"2024-09-06","current":-4.658074,"twenty":-6.575014,"median":-5.590187,"eighty":-4.732471,"marketCap":397338364},{"date":"2024-09-13","current":-4.408437,"twenty":-6.520293,"median":-5.578489,"eighty":-4.665342,"marketCap":376044078},{"date":"2024-09-20","current":-4.196954,"twenty":-6.477243,"median":-5.57069,"eighty":-4.6075,"marketCap":358004377},{"date":"2024-09-27","current":-3.78816,"twenty":-6.457997,"median":-5.564005,"eighty":-4.555487,"marketCap":323133821},{"date":"2024-10-04","current":-3.412069,"twenty":-6.444854,"median":-5.520554,"eighty":-4.463176,"marketCap":291052909},{"date":"2024-10-11","current":-3.984381,"twenty":-6.396267,"median":-5.495668,"eighty":-4.391506,"marketCap":339871688},{"date":"2024-10-18","current":-8.722034,"twenty":-6.444854,"median":-5.494185,"eighty":-4.372675,"marketCap":743998188},{"date":"2024-10-25","current":-7.426973,"twenty":-6.575014,"median":-5.518326,"eighty":-4.380219,"marketCap":633528265},{"date":"2024-10-31","current":-6.633368,"twenty":-6.626621,"median":-5.552864,"eighty":-4.385863,"marketCap":565832892},{"date":"2024-11-08","current":-7.532715,"twenty":-6.647324,"median":-5.570133,"eighty":-4.416277,"marketCap":642548116},{"date":"2024-11-15","current":-5.302508,"twenty":-6.677519,"median":-5.57069,"eighty":-4.447647,"marketCap":465602621},{"date":"2024-11-22","current":-5.400663,"twenty":-6.652589,"median":-5.56679,"eighty":-4.448989,"marketCap":474221422},{"date":"2024-11-29","current":-5.554297,"twenty":-6.650761,"median":-5.56679,"eighty":-4.454222,"marketCap":487711719},{"date":"2024-12-06","current":-4.173725,"twenty":-6.633578,"median":-5.554297,"eighty":-4.447681,"marketCap":366486409},{"date":"2024-12-13","current":-4.690106,"twenty":-6.633368,"median":-5.55038,"eighty":-4.454222,"marketCap":411828797},{"date":"2024-12-20","current":-4.600486,"twenty":-6.599635,"median":-5.518326,"eighty":-4.476607,"marketCap":403959457},{"date":"2024-12-27","current":-4.39564,"twenty":-6.598268,"median":-5.495668,"eighty":-4.47213,"marketCap":385972394},{"date":"2025-01-03","current":-4.376436,"twenty":-6.597297,"median":-5.489358,"eighty":-4.431958,"marketCap":384286107},{"date":"2025-01-10","current":-4.013689,"twenty":-6.580078,"median":-5.474874,"eighty":-4.400759,"marketCap":352434016},{"date":"2025-01-17","current":-3.945407,"twenty":-6.549815,"median":-5.463733,"eighty":-4.371161,"marketCap":346438328},{"date":"2025-01-24","current":-4.049964,"twenty":-6.531256,"median":-5.447319,"eighty":-4.329948,"marketCap":355619225},{"date":"2025-01-31","current":-3.646675,"twenty":-6.482324,"median":-5.400974,"eighty":-4.264567,"marketCap":320207195},{"date":"2025-02-07","current":-3.864323,"twenty":-6.459999,"median":-5.376271,"eighty":-4.20066,"marketCap":339318449},{"date":"2025-02-14","current":-3.102554,"twenty":-6.448423,"median":-5.308909,"eighty":-4.176092,"marketCap":272429058},{"date":"2025-02-21","current":-3.056677,"twenty":-6.434147,"median":-5.302508,"eighty":-4.119313,"marketCap":268400706},{"date":"2025-02-28","current":-2.638451,"twenty":-6.340126,"median":-5.244267,"eighty":-4.093707,"marketCap":231677119},{"date":"2025-03-07","current":-2.367458,"twenty":-6.339446,"median":-5.203025,"eighty":-4.06287,"marketCap":207881733},{"date":"2025-03-14","current":-2.630983,"twenty":-6.269217,"median":-5.198397,"eighty":-4.049964,"marketCap":231021340},{"date":"2025-03-21","current":-2.460092,"twenty":-6.255885,"median":-5.114065,"eighty":-3.984381,"marketCap":205616953},{"date":"2025-03-28","current":-2.06468,"twenty":-6.247779,"median":-5.067789,"eighty":-3.960398,"marketCap":172568018},{"date":"2025-04-04","current":-1.656911,"twenty":-6.240921,"median":-5.016723,"eighty":-3.945407,"marketCap":138486304},{"date":"2025-04-11","current":-1.456959,"twenty":-6.236945,"median":-4.994706,"eighty":-3.88409,"marketCap":121774058},{"date":"2025-04-17","current":-1.512002,"twenty":-6.221793,"median":-4.974969,"eighty":-3.861976,"marketCap":126374620},{"date":"2025-04-25","current":-1.959087,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"marketCap":163742450}],"updateTime":1745805911548}}}